...
首页> 外文期刊>Organic process research & development >Pilot Plant Preparation of tert-Butyl-4-(2-hydroxyethyl)-4-(pyrrolidin-1-yl)-piperidine-1-carboxylate, An Intermediate of Novel Antiarteriosclerotics, Via a Safe, Scalable Reformatsky-Type Reaction
【24h】

Pilot Plant Preparation of tert-Butyl-4-(2-hydroxyethyl)-4-(pyrrolidin-1-yl)-piperidine-1-carboxylate, An Intermediate of Novel Antiarteriosclerotics, Via a Safe, Scalable Reformatsky-Type Reaction

机译:通过安全,可扩展的Reformatsky型反应制备4-(2-羟乙基)-4-(吡咯烷-1-基)-哌啶-1-甲酸叔丁酯的中间体,该中间体是新型抗动脉硬化药的中间体

获取原文
获取原文并翻译 | 示例
           

摘要

Reported here is a safe, scalable process via a Refbrmatsky-type reaction of iminium salt (4) followed by Red-Al reduction giving tert-butyl-4-(2-hydroxyethyl)-4-(pyrrolidin-1-yl)-piperidine-1-carboxylate (6), an intermediate of novel antiarteriosclerotics (1), The key points of this safe process are the use of trifluoroacetic acid (TFA) for the iminium Salt formation, vigorous stirring for the Reformatsky reaction, and slow addition of methyl bromoacetate. Pilot manufacturing on the 500 L scale was achieved.
机译:这里报道的是一种安全,可扩展的过程,方法是亚硝酸盐(4)进行Refbrmatsky型反应,然后进行Red-Al还原,得到4-(2-羟乙基)-4-(吡咯烷-1-基)-哌啶叔丁基-1-羧酸盐(6),新型抗动脉硬化药(1)的中间体,此安全过程的关键是使用三氟乙酸(TFA)形成亚胺盐,剧烈搅拌以促进Reformatsky反应以及缓慢加入溴乙酸甲酯。实现了500升规模的中试生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号